相关实验视频

Updated: Jan 13, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

源自内皮前体细胞的细胞外囊泡促进糖尿病小鼠的伤口愈合,通过激活动员和新血管化

Yan Bao¹, Zhaoxiang Li¹, Lingjuan Du¹

¹Department of Vascular Surgery, Affiliated Hospital of Yunnan University, NO.176, Qing Nian Road, Wu Hua District, Kunming, Yunnan, 650021, P. R. China.

Cell biology and toxicology

|January 8, 2026

概括

源自内皮前体细胞的细胞外囊泡 (EVs) 通过增强血管生成和细胞迁移来加速糖尿病伤口愈合. 在这些EV中过度表达miR-204-5p,通过miR-204-5p/SNHG1/HDAC6通路改善治疗效果.

科学领域:

再生医学是一种再生医学.
分子生物学分子生物学
伤口治愈研究研究伤口治愈研究

背景情况:

糖尿病患者由于血管新生功能障碍而经历伤口愈合障碍.
内皮原生细胞 (EPC) 在血管修复中起着至关重要的作用.
来自EPCs的细胞外囊泡 (EVs) 正在研究它们的治疗潜力.

研究的目的:

研究EPC衍生的EVs在糖尿病小鼠中促进伤口愈合的功能.
阐明EPC-EV对糖尿病伤口修复的治疗效果背后的分子机制.
为使用EPC-EVs治疗难以愈合的糖尿病伤口提供理论基础.

主要方法:

在糖尿病小鼠中建立了全厚皮肤伤口模型.
评估EPC-EV治疗后的伤口愈合,组织病理学和循环EPC.
在细胞模型中评估了EV细胞内,细胞活力,血管生成和迁移.
研究了miR-204-5p/SNHG1/EIF4A3/HDAC6分子轴的研究.

主要成果:

在糖尿病小鼠中,EPC-EV治疗显著促进了伤口愈合,并改善了他的病理结构.
在实验室中,EPC-EVs增强了血管生成和内皮细胞迁移.
在EPC-EV中过度表达miR-204-5p进一步增强了治疗效果.
EPC-EVs释放了miR-204-5p,抑制了SNHG1的表达,这反过来又降低了HDAC6水平,从而促进了血管生成.

结论:

由EPC衍生的EVs通过增强EPC动员和血管生成,有效地加速糖尿病小鼠的伤口修复.
治疗机制涉及miR-204-5p/SNHG1/HDAC6信号通路.
EPC-EVs代表了一种有前途的治疗策略,用于管理糖尿病伤口并发症.

关键词:

糖尿病糖尿病糖尿病欧洲投资基金4A3A3 在EPC-EV中使用EPC-EV.在米R-204-5p.在SNHG1中,SNHG1是SNHG1.伤口愈合伤口愈合

更多相关视频

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

相关概念视频

Clinical Applications of Epidermal Stem Cells

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

Mechanism of Angiogenesis

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...